Patient treatment preference as a predictor of response and attrition in treatment for chronic depression

Depression and Anxiety

Volumn 29, Issue 10, 2012, Pages 896-905

  Steidtmann, Dana ^a   Manber, Rachel ^a   Arnow, Bruce A ^a   Klein, Daniel N ^b   Markowitz, John C ^c   Rothbaum, Barbara O ^d   Thase, Michael E ^e   Kocsis, James H ^f  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

treatment engagement; treatment outcome

Indexed keywords

AMFEBUTAMONE; ESCITALOPRAM; LITHIUM; MIRTAZAPINE; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; BRIEF SUPPORTIVE PSYCHOTHERAPY; COGNITIVE THERAPY; CONTROLLED STUDY; DSM-IV; FEMALE; HAMILTON SCALE; HEALTH BELIEF; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OPEN STUDY; PATIENT PREFERENCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT ATTRITION; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT PREFERENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; PSYCHOTHERAPY, BRIEF; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867098308     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.21977     Document Type: Article

References (32)

1. World Health Organiziation. Depression Management Fact Sheet. 2011.
2. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62 (6): 593-602.
3. Swift JK, Callahan JL, Vollmer BM,. Preferences. J Clin Psychol 2011; 67 (2): 155-165.
4. Kwan BM, Dimidjian S, Rizvi SL,. Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression. Behav Res Ther 2010; 48 (8): 799-804.
5. van Schaik DJ, Klijn AF, van Hout HP, et al. Patients' preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry 2004; 26 (3): 184-189.
6. Chilvers C, Dewey M, Fielding K, et al. Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ 2001; 322 (7289): 772-775.
7. Kocsis JH, Leon AC, Markowitz JC, et al. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. J Clin Psychiatry 2009; 70 (3): 354-361.
8. Lin P, Campbell DG, Chaney EF, et al. The influence of patient preference on depression treatment in primary care. Ann Behav Med 2005; 30 (2): 164-173.
9. Leykin Y, Derubeis RJ, Gallop R, et al. The relation of patients' treatment preferences to outcome in a randomized clinical trial. Behav Ther 2007; 38 (3): 209-217.
10. Markowitz JC, Kocsis JH, Bleiberg KL, et al. A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients. J Affect Disord 2005; 89 (1-3): 167-175.
11. Manber R, Chambers AS, Hitt SK, et al. Patients' perception of their depressive illness. J Psychiatr Res 2003; 37 (4): 335-343.
12. Fernandez y Garcia Y, Franks P, Jerant A, et al. Depression treatment preferences of Hispanic individuals: exploring the influence of ethnicity, language, and explanatory models. J Am Board Fam Med 2011; 24 (1): 39-50.
13. Kocsis JH, Gelenberg AJ, Rothbaum BO, et al. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry 2009; 66 (11): 1178-1188.
14. Hamilton M,. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6 (4): 278-296.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-4th Edition Text Revision. 2004.
16. First MB, Spitzer RL, Gibbon M, Williams JBW,. Structured Clinical Interview for DSM-IV Axis-I Disorders, Patient Edition (SCID-I/P, Version 2.0). New York: Bio-metrics Research Dept., New York State Psychiatric Institute; 1995.
17. Keller MB, Shapiro RW,. " Double depression": superimposition of acute depressive episodes on chronic depressive disorders. Am J Psychiatry 1982; 139 (4): 438-442.
18. First MB, Gibbon M, Spitzer RL, et al. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington, DC: American Psychiatric Press, Inc.; 1997.
19. Crismon ML, Trivedi M, Pigott TA, et al. The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder. J Clin Psychiatry 1999; 60 (3): 142-156.
20. Fava M, Rush AJ, Trivedi MH, et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am 2003; 26 (2): 457-494.
21. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54 (5): 573-583.
22. Fawcett J, Epstein P, Fiester SJ, et al. Clinical management-imipramine/ placebo administration manual. NIMH Treatment of Depression Collaborative Research Program. Psychopharmacol Bull 1987; 23 (2): 309-324.
23. Elkin I, Shea MT, Watkins JT, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry 1989; 46 (11): 971-982; discussion 983.
24. McCullough JP,. Treatment for Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy. New York, NY: Guilford Press; 2000.
25. Frank JD,. Eleventh Emil A. Gutheil memorial conference. Therapeutic factors in psychotherapy. Am J Psychother 1971; 25 (3): 350-361.
26. Markowitz JC, Manber R, Rosen P,. Therapists' responses to training in brief supportive psychotherapy. Am J Psychother 2008; 62 (1): 67-81.
27. Klein DN, Kocsis JH, McCullough JP, et al. Symptomatology in dysthymic and major depressive disorder. Psychiatr Clin North Am 1996; 19 (1): 41-53.
28. Ley P, Helbig-Lang S, Czilwik S, et al. Phenomenological differences between acute and chronic forms of major depression in inpatients. Nord J Psychiatry 2011; 65 (5): 330-337.
29. Gueorguieva R, Krystal JH,. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 2004; 61 (3): 310-317.
30. Gum AM, Arean PA, Hunkeler E, et al. Depression treatment preferences in older primary care patients. Gerontologist 2006; 46 (1): 14-22.
31. Kocsis JH, Gelenberg AJ, Rothbaum B, et al. Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment. J Affect Disord 2008; 110 (1-2): 55-61.
32. Khalsa SR, McCarthy KS, Sharpless BA, et al. Beliefs about the causes of depression and treatment preferences. J Clin Psychol 2011; 67 (6): 539-549.